ONCOLife Issues
Featured Articles
Trending Articles
FDA-Cleared Utepreva Device Aims to Improve Early Endometrial Cancer Detection
Cancer | 22 April 2026
Opaganib Shows Dual Preclinical Promise in Neuroblastoma and Triple- Breast Cancer
ONCOLife | 22 April 2026
Ozekibart Shows Encouraging Late-Line Activity in Metastatic Colorectal Cancer
ONCOLife | 22 April 2026
FDA Gives Priority Review to PADCEV Plus Pembrolizumab in MI Bladder Cancer
FDA & EMA | 20 April 2026
AACR26 Data Show Multi-Biomarker MCED Approach Improves Early Cancer Detection
ONCOLife | 17 April 2026
FDA Grants Breakthrough Status to First Urine-Based Multi-Cancer Early Detection Test
ONCOLife | 16 April 2026
AI Nodule Detection Helps Sarasota Memorial Reach 75% Early Lung Cancer Diagnosis
AI | 15 April 2026
Zenocutuzumab Gains NCCN Support as FDA Review Advances in Cholangiocarcinoma
FDA & EMA | 15 April 2026
Phase 2 Data Position Trastuzumab Pamirtecan as a Promising Option in Endometrial Cancer
ONCOLife | 13 April 2026
Mocertatug Rezetecan Shows Strong Responses in Ovarian and Endometrial Cancers
FDA & EMA | 12 April 2026
FDA Grants Priority Review to Ifinatamab Deruxtecan in Pretreated ES-SC Lung Cancer
FDA & EMA | 13 April 2026
Neladalkib Reaches FDA Review for TKI-Pretreated ALK+ Non-Small Cell Lung Cancer
FDA & EMA
9 April 2026
FDA Grants Breakthrough Status to WU-CART-007 for T-Cell Leukemias and Lymphomas
FDA & EMA
1 April 2026
New IHC Biomarker Test Predicts Which Gastric Cancer Patients Benefit from Immunotherapy
ONCOLife
30 March 2026
AI Predicts Chemotherapy Benefit in Breast Cancer Using Routine Pathology Slides
Clinical Trials
30 March 2026
FDA Approves Agilent’s PD-L1 Test to Guide KEYTRUDA Use in Esophageal and GEJ Carcinoma
FDA & EMA
28 March 2026
Light-Activated Copper Nanoparticles Trigger Cuproptosis in Drug-Resistant Cancer Cells
ONCOLife
27 March 2026
BioNTech Showcases Promising Bispecific and ADC Data in Lung Cancer at ELCC 2026
ONCOLife
25 March 2026
Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer
ONCOLife
22 March 2026
Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors
ONCOLife
23 March 2026
TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis
Biotech
20 March 2026